Latest News

Clinic responsible for misdiagnosing newborn’s meningitis, must pay millions


 

ED physician found not liable for embolism, jury finds

A Missouri doctor accused of incorrectly treating a woman’s embolism has been found not liable for her death, reports a story in Missouri Lawyers Media.

The woman went to her local hospital’s ED complaining of pain and swelling in her leg. At the ED, an emergency physician examined her and discovered an extensive, visible thrombosis. No other symptoms were noted.

In the past, such a finding would have prompted immediate hospital admission. But the standard of care has evolved. Now, many doctors first prescribe enoxaparin sodium (Lovenox), an anticoagulant used to treat deep-vein thrombosis. This was the option chosen by the Missouri emergency physician to treat his patient. After administering a first dose of the drug, he wrote a script for additional doses; consulted with his patient’s primary care physician; and arranged for the patient to be seen by him, the ED physician, the following day.

At the drugstore, though, the woman became ill, and an emergency medical services crew was alerted. Despite its quick response, the woman died en route to the hospital. No autopsy was later performed, and it was generally presumed that she had died of a pulmonary embolism.

Following the woman’s death, her family sued the emergency physician, alleging that his failure to admit the woman to the hospital most likely delayed treatment that could have saved her life.

The defense pushed back, arguing that the ED physician had followed the standard of care. “Even if she [had] come into the ER with full-blown [pulmonary embolism],” says the attorney representing the emergency physician, “the first thing you do is give Lovenox. It is just one of those rare circumstances where you can do everything right, but the patient can still die.”

The trial jury agreed. After deliberating for more than an hour, it found that the emergency physician was not responsible for the patient’s death.

At press time, there was no word on whether the plaintiffs planned to appeal.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Perinatal HIV nearly eradicated in U.S.
Federal Practitioner
CDC backs FDA’s call for second COVID booster for those at high risk
Federal Practitioner
Dried blood spot test validated for HIV, hep B, and hep C
Federal Practitioner
Diagnosis by dog: Canines detect COVID in schoolchildren with no symptoms
Federal Practitioner
FMT in a pill: FDA approves second product to prevent C. diff recurrence
Federal Practitioner
UTI imaging falls short in some primary care settings
Federal Practitioner
White House to end COVID vaccine mandate for federal workers
Federal Practitioner
New outbreaks of Marburg virus disease: What clinicians need to know
Federal Practitioner
FDA approves first RSV vaccine for older adults
Federal Practitioner
COVID-19 and psoriasis: Is there a link?
Federal Practitioner